The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

DocuSign has experienced a notable decline in its stock price, dropping by 15.61% over the past week. This movement comes amidst a series of analyst reports maintaining a ‘Hold ...

Key Takeaways Docusign's first-quarter billings missed estimates, and it lowered its full-year billings outlook.The ...

The company lowered its full-year earnings forecast to $14.58 to $14.78 per share, down from prior guidance of $14.95 to ...

The most recent trading session ended with DocuSign (DOCU ... revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks ...

The most recent trading session ended with DocuSign (DOCU) standing at $90.27 ... that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, ...

DocuSign (DOCU) closed the latest trading day at $75.42, indicating a -1.27% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.13%. At the same ...

Following the earnings announcement, DocuSign’s stock price increased by 8.45% in after-hours trading to $81.01. This rise contrasts with the day’s earlier decline of 6.78%, suggesting a ...

DocuSign stock is a sell since the technicals are mixed ... its relevance will be on the decline. The 50-day SMA had a bullish golden cross with the 200-day SMA back at the start of October.

Shares of DocuSign (DOCU ... got a lift as Bernstein analysts upgraded the stock, saying the recent drop made the shares attractive. The decline in oil prices sent shares of Marathon Petroleum ...